Author:
Buenestado Amparo,Chaumais Marie-Camille,Grassin-Delyle Stanislas,Risse Paul-André,Naline Emmanuel,Longchampt Elisabeth,Tenor Hermann,Devillier Philippe
Publisher
Public Library of Science (PLoS)
Reference59 articles.
1. The preclinical pharmacology of roflumilast - a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease;A Hatzelmann;Pulm Pharmacol Ther,2010
2. Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD;MA Giembycz;Drug Des Devel Ther,2010
3. Susceptibility to exacerbation in chronic obstructive pulmonary disease;JR Hurst;N Engl J Med,2010
4. Frequent exacerbations of chronic obstructive pulmonary disease--a distinct phenotype?;DP Tashkin;N Engl J Med,2010
5. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro;A Hatzelmann;J Pharmacol Exp Ther,2001
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献